Transgenomic, Precipio Diagnostics Ink Merger Agreement

Oct 13, 2016

|

NEW YORK (GenomeWeb) – Transgenomic and privately held Precipio Diagnostics said today that they have entered into a merger agreement that will make Precipio a wholly owned subsidiary of Transgenomic, with Transgenomic adopting the name Precipio, Inc.

The merger, expected to close in 2016, is pending approval by Transgenomic shareholders.

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

Breaking News

The Scan

Now You Can Read Them, Now You Can't

What happens to scientific papers when certain journals are no longer published? Some scientists are trying to make sure they don't disappear forever.

The Mouths of Heavy Drinkers Are Disgusting

A study in Microbiome finds that heavy drinkers have an unhealthy mix of bacteria in their mouths.

For Health or For Fun?

Doctors and patients are still trying to figure out what role at-home genetic testing should play in healthcare, Newsweek says.

This Week in Genome Research

In Genome Research this week, mismatch repair deficiency in C. elegans, retracing transcriptions start site evolution in the human genome, and more.

Main menu